InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,419.20
(
0.00%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
83.42
(
0.35%
)
Bitcoin
64,183.33
(
0.29%
)
Post# of 6034
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

dia76ca

Send PM Follow Ignore
Followers 57
Posts 5697
Boards Moderated 0
Alias Born 12/13/2004

dia76ca

Re: None

Wednesday, 09/13/2017 3:18:00 PM

Wednesday, September 13, 2017 3:18:00 PM

Post# of 6034
$HTBX Heat Biologics Granted Type C Meeting with FDA to Discuss Registrational Pathway for HS-110 in Combination with Opdivo(R) as a Treatment for Non-Small Cell Lung Cancer http://ir.heatbio.com/press-releases/detail/573

Why would HTBX want this meeting? Obviously they are having good results with the phase II NSCLC trial of HS-110 plus Opdivo. They are already expanding the number of trial sites. They want to know if they might receive accelerated approval based on these phase II results!

Who else would like to know what the registrational pathway might be? Answer: potential partners. HTBX has said that there is partnering interest and that they are open to partnering. The results of this Type C meeting will be important for the partnering talks.

"The refusal of the real is the number one dogma of our time" Rene Girard

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NHWK News
More NHWK News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!